Industry News

Bracco Imaging Acquires SurgVision

By Medimaging International staff writers
25 Oct 2017

Image: Bracco Imaging has acquired SurgVision (Photo courtesy of iStock).Bracco Imaging S.p.A. (Milan, Italy), a diagnostic imaging company, has acquired SurgVision ('t Harde, The Netherlands), which focuses on developing a real-time Fluorescence image guided surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

Bracco Imaging S.p.A., a part of the Bracco Group, offers products and solutions for all key diagnostic imaging modalities, such as X- ray imaging (including computed tomography, interventional radiology, and cardiac catheterization), magnetic resonance imaging, contrast enhanced ultrasound, and nuclear medicine through radioactive tracers. It also offers various medical devices and advanced administration systems for contrast imaging products in the fields of radiology.

Fluorescence image guided surgery is an intra-operative optical technique to assist surgeons in distinguishing tumors from surrounding tissue, using a combined infrared camera and contrast agent approach. SurgVision's targeting solution is expected to provide significant improvements as compared to competing modalities and products, due to advanced features of its optical camera and sensitive targeting performance of its new imaging agent.

"With the acquisition of SurgVision, one of the most advanced companies in a very promising field, we intend to address a relevant, unmet medical need for oncology patients who have to undergo tumor removal surgery," said Fulvio Renoldi Bracco, Chief Executive Officer at Bracco Imaging. "SurgVision platform expands our imaging solutions for healthcare professionals in oncology and reinforces our long-lasting commitment to patient care."

"The investment in Surgvision provides Bracco Imaging with key competencies and technologies strategically adjacent to our core business," said Micol Fornaroli, Chief Strategy Officer at Bracco Imaging. "And at the same time, it will accelerate the development of the projects currently in scope of our Research and Development efforts."

"The acquisition of SurgVision by Bracco is a vote of confidence for the field of fluorescence image- guided surgery and for the achievements so far by the SurgVision team," said Ton van den Hoven, Chief Executive Officer at SurgVision. "The expertise and commitment from Bracco will allow SurgVision to continue developing a solution that delivers on the potential of important clinical benefits for patients."



E-mail Print
FaceBook Twitter Google+ Linked in

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical devices and advanced imaging agents injection systems
More info

More articles about Bracco

05 Apr 2017
Bracco Imaging Announces Strategic Investment in PHS Technologies Group
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.
Read More

Additional news

20 May 2019
Beckman Coulter Introduces New Total Laboratory Automation Solution
Beckman Coulter’s latest addition to its automation portfolio, the DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval.
Read More
20 May 2019
Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019
Ortho Clinical Diagnostics sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona.
Read More
18 May 2019
AI More Accurate at Predicting Heart Attacks than Physicians
Researchers from the Turku PET Centre have developed an algorithm that “learned” how imaging data interacts by repeatedly analyzing 85 variables in 950 patients with known six-year outcomes.
Read More
18 May 2019
New AI Method Predicts Breast Cancer Five Years in Advance
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to predict a woman’s future risk of breast cancer.
Read More
18 May 2019
Weak AI security Exposes IoT Medical Devices to Risk of Cyberattacks
The proliferation of healthcare internet-of-things (IoT) devices, along with unpartitioned networks, insufficient access controls and the reliance on legacy systems has exposed a vulnerable attack surface that can be exploited by cybercriminals determined to steal personally identifiable information (PII) and protected health information (PHI), in addition to disrupting healthcare delivery processes.
Read More
18 May 2019
Disposable Anesthesia Device Demand Driven by Lower Risk of Transmitting Infections
The global anesthesia devices market is expected to register a CAGR of more than 6% during the period 2019-2023, driven by increasing demand due to advances in anesthesia technology and growing demand for disposable anesthesia devices.
Read More
18 May 2019
MRI Systems Market to Reach USD 11.72 Billion by 2025
The global Magnetic Resonance Imaging (MRI) systems market is expected to grow at a CAGR of 6.4% between 2018 and 2025 to reach USD 11.72 billion by 2025, driven by increased healthcare spending and sophisticated healthcare infrastructure in the developed nations, as well as recent technological advancements.
Read More
18 May 2019
New AR Patient Solution Applies VR to Thoracic Surgery
Surgical Theater, a provider of virtual and augmented reality healthcare services, has launched its first ever 360° Augmented Reality (AR) patient engagement solution that will allow thoracic surgeons to view patient-specific virtual reconstructions in AR.
Read More
08 May 2019
Technological Advancements and Multi-Modality Systems Driving X-ray Detector Market
The global healthcare X-ray detectors market is projected to grow at a CAGR of 6.14% during the forecast period 2018-2024, driven primarily by technological advancements and adoption of multi-modality imaging systems in hospitals.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions